Services of MTRC

MTRC is pleased to announce its membership in ABHI, the UK’s leading industry association for health technology (HealthTech). By joining ABHI, MTRC strengthens its commitment to supporting the industry with high-quality insights and strategic guidance, ensuring that companies remain at the forefront of innovation in an evolving healthcare landscape.

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to understand the potential scope of our support better. From the week of the 10th of March, we plan to work on 21 projects. Review the complete list of planned activities in this post.

MTRC announces the start of the new service - Analysis of Tender Requirements for Medical Devices. Our team thoroughly reviews the criteria that procurement bodies use to evaluate bids. We break down how factors like price, quality, clinical and economic evidence, and sustainability influence decision-making. With these insights, we guide you in aligning your product’s unique strengths to the specific expectations of different European markets.

MTRC developed an analytical White Paper featuring the Health Economic Evidence Requirements for Medical Devices across the BIG5 European markets: England, France, Germany, Italy and Spain.

We are pleased to announce the expansion of our HEOR Department with the addition of Elizaveta Fedina, an experienced health economist with a strong background in health technology assessment (HTA) and economic evaluation.

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to understand the potential scope of our support better. From the week of the 24th of February, we plan to work on 15 projects. Review the complete list of planned activities in this post.

MTRC developed a White Paper exploring how value dossiers support payer negotiations, evidence synthesis, and strategic value communication in the MedTech sector. In this White Paper, we outline best practices for structuring value dossiers, tailoring messaging for different stakeholders, and leveraging them as a central evidence repository.

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to understand the potential scope of our support better. From the week of the 10th of February, we plan to work on 14 projects. Review the complete list of planned activities in this post.

MTRC announces the launch of a new service designed to further enhance the decision-making process: Market Size Analysis for medical devices in Europe.

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to understand the potential scope of our support better. From the week of the 27th of January, we plan to work on 17 projects. Review the complete list of planned activities in this post.

MTRC pleased to share our key insights on the most important developments in European market access for medical technologies and in-vitro diagnostic tests in 2024.

MTRC developed a White Paper featuring an analysis of five rapid HTAs and strategic recommendations for evidence generation strategy in Tuscany, Italy. In this White Paper, we reviewed five rapid HTA reports from the Tuscany region to highlight the evidence requirements of the HTA program.